Momenta to Present at the Leerink Swann 2012 Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced its participation at the upcoming Leerink Swann 2012 Global Healthcare Conference taking place in New York, NY. Richard P. Shea, Chief Financial Officer, will participate in a question and answer session on Wednesday, February 15, 2012 at 8:30 a.m. ET. A live audio webcast of the presentation will be available on the "Investors" section of the Company's website
located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website approximately one hour after the event and will be available through May 15, 2012.
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release. Our logo, trademarks, and service marks are the property of Momenta
Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.
CONTACT: Beverly Holley
Director, Investor Relations
Momenta Pharmaceuticals, Inc.
Source: Momenta Pharmaceuticals
News Provided by Acquire Media
Close window | Back to top